Press Releases

and/or
565 News Releases found
Peter Scardino
In the Modern Post-PSA Era, Prostate Cancer Surgery May Not be Necessary for Some Patients

Investigators at Memorial Sloan Kettering Cancer Center, along with collaborating teams at the Cleveland Clinic and the University of Michigan, have completed the first large-scale, multi-institutional study of prostate cancer death after standard treatment to remove the prostate since PSA screening has become widely used as a method to screen for the disease.
Joan Massagué, PhD
Researchers Find Genetic Key to Breast Cancer's Ability to Survive and Spread

New research led by investigators at Memorial Sloan Kettering Cancer Center sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
Research Reveals What Drives Lung Cancer's Spread

A new study by researchers at Memorial Sloan Kettering Cancer Center reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone - the two most prominent sites of lung cancer relapse.
Vincent Miller
Study Shows Drug Combination Improves Outcome for Advanced Non-Small Cell Lung Cancer

A new, international study found that the combination of two drugs delays disease progression for patients with advanced non-small cell lung cancer (NSCLC).
Philip Paty
Surgery Not Necessary for Most Late-Stage Colorectal Cancers

A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon.
Dr. Charles Sawyers
Memorial Sloan Kettering Investigator Named Dream Team Leader by Stand Up To Cancer

Charles Sawyers, MD, Director of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center and a Howard Hughes Medical Institute investigator, has been named a "Dream Team" leader by Stand Up To Cancer and will co-lead a collaborative team that will receive $15 million to study targeted therapies to treat women's cancers.
Picture: Joan Massagué
Genes Found to Play a Role in Breast Cancer's Spread to the Brain

New research led by investigators at Memorial Sloan Kettering Cancer Center identifies three genes that specifically mediate the metastasis, or spread, of breast cancer to the brain and illuminates the mechanisms by which this spread occurs.
Charles Sawyers, MD
Drug Shows Activity in Men with Advanced Prostate Cancer

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.
Media Advisory
Genetic Abnormality May Increase Risk of Blood Disorders

Researchers at Memorial Sloan Kettering Cancer Center have shown for the first time that a tendency to develop some blood disorders may be inherited.
Dr. Tim A. Ahles
NIH Awards $15.9 Million to CCNY and Memorial Sloan Kettering to Create Partnership to Address Cancer Disparities

The National Institutes of Health's National Cancer Institute has awarded The City College of New York and Memorial Sloan Kettering Cancer Center a $15.9 million grant to implement a unique partnership in cancer research, education, and outreach.